Analysts now cite a slightly lower fair value estimate for EBOS Group, trimming the indicative price target from around NZ$33.63 to NZ$33.31 as modest adjustments to the discount rate, profit margin and assumed future P/E feed through their models.
What's in the News
- EBOS Group Limited (ASX:EBO) was removed from the S&P/ASX 200 Index. This change may affect how index funds and some institutional investors hold or trade the stock (Key Developments).
Valuation Changes
- Fair Value: The indicative fair value per share is now NZ$33.31, slightly lower than the prior NZ$33.63.
- Discount Rate: The discount rate used in the model has risen slightly from 7.27% to 7.62%.
- Revenue Growth: Assumed A$ revenue growth remains effectively unchanged at about 4.96% in both the prior and updated models.
- Net Profit Margin: The assumed net profit margin has edged down slightly from 1.97% to 1.96%.
- Future P/E: The future P/E assumption is now 24.14x, fractionally lower than the previous 24.17x.
Have other thoughts on EBOS Group?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.